curdlan has been researched along with celecoxib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cho, ML; Choi, J; Lee, AR; Lee, SY; Min, BM; Min, HK; Park, SH | 1 |
1 other study(ies) available for curdlan and celecoxib
Article | Year |
---|---|
Vitronectin-derived bioactive peptide prevents spondyloarthritis by modulating Th17/Treg imbalance in mice with curdlan-induced spondyloarthritis.
Topics: Animals; beta-Glucans; Celecoxib; Cytokines; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation; Humans; Integrin alphaVbeta3; Integrin beta1; Mice; Peptides; Signal Transduction; Spleen; Spondylarthritis; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Th17 Cells; Vitronectin | 2022 |